Canberra residents are facing challenges accessing the shingles vaccine, Shingrix, despite a surge in demand. The vaccine’s efficacy and the struggles of those affected by shingles have spurred calls for broader access to the program.
Paul Dowden, who endured the agonizing effects of shingles multiple times, including recently despite being fully vaccinated, emphasized the vaccine’s impact on his ability to care for his disabled son. However, because he doesn’t qualify under the National Vaccination Program, he had to pay around $300 per dose for Shingrix .
The National Vaccination Program provides free Shingrix vaccinations to certain groups, including those aged 65 and over, Indigenous Australians aged 50 and over, and immunocompromised individuals with specified medical conditions . However, pharmacies in Canberra are struggling to meet demand, with waitlists exceeding 100 patients .
Colette Gilmour’s experience highlights the challenge of obtaining the second dose of Shingrix, as stock shortages have hindered her efforts to complete the vaccination process .
Despite assurances from health officials that there is no supply shortage, the federal government is in discussions with suppliers to increase vaccine availability to meet the high demand .
The overwhelming interest in Shingrix underscores its efficacy, especially in individuals aged 50 and over, where it is more than 90% effective at preventing shingles . This effectiveness has prompted individuals like Ms. Gilmour to patiently await their free vaccine eligibility at 65, given the considerable cost savings.
